Despite market turmoil, Atomo Diagnostics – the biotech backed by billionaire developer Lang Walker and former Macquarie bank boss Allan Moss – is pushing head with its planned ASX float after receiving increased interest on the back of the conronavirus pandemic.
Late last week its broker, Canaccord Genuity, mulled pulling the initial public offer but in light of the heightened interest from four diagnostic companies in China, Europe and the United States about its self-testing blood kits for coronavirus, Atomo is still seeking to raise $30 million at 20¢ a share.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
